search
Back to results

Family Centred Early Intervention of Infants With Congenital Heart Disease

Primary Purpose

Congenital Heart Disease in Children

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
early motor intervention
Sponsored by
University Children's Hospital, Zurich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Congenital Heart Disease in Children focused on measuring congenital heart diseases, open heart surgery, motor development, early intervention, family centred, physiotherapy

Eligibility Criteria

2 Months - 12 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Infants born with severe cyanotic and acyanotic congenital heart disease (e.g. tetralogy of Fallot, pulmonary atresia, transposition of the great arteries, atrial/ventricular septal defects, double outlet right ventricle, ...) who undergo open-heart surgery once before the first 3-6 months of their life
  • Parents able to comprehend the patient information linguistically and cognitively
  • Informed consent of parents as documented by signature

Exclusion Criteria:

  • Infants with hypoplastic left heart syndrome as they need to undergo several open-heart surgeries within the first period of their life.
  • Infants with trisomy 21 and other syndromes like 22q11 microdeletion syndrome, CHARGE syndrome that are often associated with CHD. These infants often show additional cognitive impairments that might confound the effect of our intervention.

Sites / Locations

  • University Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

standard care

intervention group

Arm Description

Control subject will receive standard care of treatment

intervention group will receive early intervention

Outcomes

Primary Outcome Measures

Dropout rate
The primary outcome will test the procedure for its acceptability, estimation the likely rates of recruitment and retention of subjects and the calculation of appropriate sample size. Further objectives are the usefulness of the outcome assessment measures.

Secondary Outcome Measures

Full Information

First Posted
November 23, 2020
Last Updated
September 18, 2023
Sponsor
University Children's Hospital, Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT04666857
Brief Title
Family Centred Early Intervention of Infants With Congenital Heart Disease
Official Title
Family Centred Early Intervention to Improve Motor Development of Infants With Severe Congenital Heart Disease
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
May 31, 2021 (Actual)
Primary Completion Date
December 19, 2022 (Actual)
Study Completion Date
February 20, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Children's Hospital, Zurich

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
In this study the investigators aim to test the feasibility for therapists and acceptability to parents of an early motor intervention for infants with congenital heart disease (CHD) after open heart surgery. This intervention will be compared to the standard care of treatment that is recommended for infants with congenital heart disease at the University Children Hospital Zurich.
Detailed Description
In this feasibility pilot randomised study children will be randomly assigned to a control and an intervention group. Children of the control group will receive standard of care for infants with severe CHD: cardiac surveillance, counselling and screening at the University Children's Hospital Zurich and standardised developmental checkups by their paediatrician. Physiotherapy is normally not comprised in standard of care, but some infants may receive physiotherapy, if they present with obvious signs of motor developmental delay, detected by the paediatrician later on in their life. Once enrolled in this study, an infant of the control group will not receive early motor intervention as an infant enrolled in the intervention group. Infants randomly assigned to the intervention group will receive early motor intervention, which will be based on the results of our qualitative study. It will comprise supporting parents by a paediatric physiotherapist. Parents will be guided on how to best stimulate their infant's development during daily activities. Parents will be actively involved in the intervention with the aim to challenge their infant at the limit of its postural capacity and thus help the infant to optimize its motor repertoire. The intervention will start after baseline with infants aged 3-6 months and end after three months with infants aged 6-9 months. The intervention will start at home, then alternating at the Children's Hospital and at home. Telephone or video counselling will be provided to support parents if needed. The order may change according to the needs of the family when necessary and adjusted to best fit the daily routine the family.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Heart Disease in Children
Keywords
congenital heart diseases, open heart surgery, motor development, early intervention, family centred, physiotherapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
prospective monocentric single-blinded, two-arm feasibility randomised controlled interventional pilot trial
Masking
Outcomes Assessor
Masking Description
Assessors will be blinded to the allocation of participants
Allocation
Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
standard care
Arm Type
No Intervention
Arm Description
Control subject will receive standard care of treatment
Arm Title
intervention group
Arm Type
Experimental
Arm Description
intervention group will receive early intervention
Intervention Type
Other
Intervention Name(s)
early motor intervention
Intervention Description
infants with CHD after open heart surgery will receive early intervention
Primary Outcome Measure Information:
Title
Dropout rate
Description
The primary outcome will test the procedure for its acceptability, estimation the likely rates of recruitment and retention of subjects and the calculation of appropriate sample size. Further objectives are the usefulness of the outcome assessment measures.
Time Frame
"3 up to 6 months of age" (baseline) and at "12 months of age"
Other Pre-specified Outcome Measures:
Title
Hammersmith Infant Neurological Examination
Description
The Hammersmith Infant Neurological Examination assesses different aspects of neurological function. the higher the scores the better, the range depends on the child's abilities metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline) and at "12 months of age"
Title
General Movements
Description
The General Movement assessment is a video-based, non-invasive way to identify neurological deviations that may lead to neurodevelopmental disorders later in life. The more variables the motor output of infants, the better infants' neuromotor development will be. metric: categorial
Time Frame
"3 up to 6 months of age" (baseline)
Title
Infant Motor Profile
Description
The Infant Motor Profile is a standardised and qualitative method to assess motor behaviour in infants, a 15 minutes, video-based assessment tool, consists of 5 domains: motor variation, adaptability, symmetry, fluency and performance. The higher the score, the better - the range depends on the child's abilities and is age dependent metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention), at "12 months of age"
Title
Alberta Infant Motor Scale Change in being assessed at different time points at baseline, at the end of the intervention after three months and at follow up
Description
The Alberta Infant Motor Scale is an observational measure of infants' gross motor development from birth until 18 months consisting of 58 items, measuring infants' performance; The higher the score, the better, the range depends on the child's abilities and is age dependent metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
Title
Bayley Scale for Infant and Toddlers Development
Description
Bayley Scale for Infant and Toddlers Development is an internationally used and validated battery to assesses key domains of cognition, language, socio-emotional, motor and adaptive behaviour by standardized observation and rating of the play behaviour of children the higher the scores the better, the range depends on the child's abilities and is age dependent metric: ordinal
Time Frame
"around 12 months of age"
Title
Parental Stress Index
Description
The Parental Stress Index investigates parental stress of children with all different kind of diagnoses, consists of 5 subscales assessing areas where parental strain is high; the Parental Stress Index consists of 48 items the lower, the score the better metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
Title
Brief Symptom Inventory 18
Description
The Brief Symptom Inventory 18 contains a three six-item scales somatization, depression, and anxiety as well as the Global Severity Index the lower, the score the better metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
Title
Parental Overprotection Measure
Description
The Parental Overprotection Measure assesses parenting behaviours that restrict a child's exposure to situations containing perceived threat or harm. the higher the scores the more parents protect their children metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
Title
Family Empowerment Scale
Description
The Family Empowerment Scale measures empowerment of families. It consists of three subscales, family, service system and community/political. We use the subscale family to gather relevant information as a result of an intervention. the higher the scores the more the family feels empowered metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
Title
Quality of life form Short Form 36
Description
The Quality of life form Short Form 36 is a widely used questionnaire assessing self-reported health related quality of life the lower the score the better metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
Title
Pediatric Quality of Life Inventory
Description
The Pediatric Quality of Life Inventory measures quality of life of infants aged 1- 24 months. the higher the scores the more the quality of life is affected. metric: ordinal
Time Frame
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Months
Maximum Age & Unit of Time
12 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Infants born with severe cyanotic and acyanotic congenital heart disease (e.g. tetralogy of Fallot, pulmonary atresia, transposition of the great arteries, atrial/ventricular septal defects, double outlet right ventricle, ...) who undergo open-heart surgery once before the first 3-6 months of their life Parents able to comprehend the patient information linguistically and cognitively Informed consent of parents as documented by signature Exclusion Criteria: Infants with hypoplastic left heart syndrome as they need to undergo several open-heart surgeries within the first period of their life. Infants with trisomy 21 and other syndromes like 22q11 microdeletion syndrome, CHARGE syndrome that are often associated with CHD. These infants often show additional cognitive impairments that might confound the effect of our intervention.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bea Latal, Dr. med.
Organizational Affiliation
University Children's Hospital, Zurich
Official's Role
Study Director
Facility Information:
Facility Name
University Children's Hospital
City
Zürich
ZIP/Postal Code
8032
Country
Switzerland

12. IPD Sharing Statement

Learn more about this trial

Family Centred Early Intervention of Infants With Congenital Heart Disease

We'll reach out to this number within 24 hrs